{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:35:46Z","timestamp":1792089346197,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02386-7","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T19:03:37Z","timestamp":1663268617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Development of Novel Solid Nanostructured Lipid Carriers for Bioavailability Enhancement Using a Quality by Design Approach"],"prefix":"10.1208","volume":"23","author":[{"given":"Neha","family":"Bajwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Mahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srishti","family":"Naryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preet Amol","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"2386_CR1","doi-asserted-by":"publisher","unstructured":"Beg S, Saini S, Bandopadhyay S, Katare O, Singh B. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques. Drug development and industrial pharmacy. 2018;44(3):407\u201320. Available from: https:\/\/doi.org\/10.1080\/03639045.2017.1395459","DOI":"10.1080\/03639045.2017.1395459"},{"key":"2386_CR2","doi-asserted-by":"publisher","unstructured":"Cunha S, Costa CP, Loureiro JA, Alves J, Peixoto AF, Forbes B, et al. Double optimization of rivastigmine-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery using the quality by Design (QbD) approach: formulation variables and instrumental parameters. Pharmaceutics. 2020;12(7):599. Available from: https:\/\/doi.org\/10.3390\/pharmaceutics12070599.","DOI":"10.3390\/pharmaceutics12070599"},{"key":"2386_CR3","doi-asserted-by":"publisher","unstructured":"Agrawal Y, Patil K, Mahajan H, Potdar M, Joshi P, Nakhate K, et al. In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach. Drug Delivery. 2022;29(1):1112\u201321. Available from: https:\/\/doi.org\/10.1080\/10717544.2022.2058651","DOI":"10.1080\/10717544.2022.2058651"},{"key":"2386_CR4","doi-asserted-by":"publisher","unstructured":"Javed MN, Alam MS, Waziri A, Pottoo FH, Yadav AK, Hasnain MS, et al. QbD applications for the development of nanopharmaceutical products. Pharmaceutical quality by Design: Elsevier; 2019. p. 229\u201353. Available from: https:\/\/doi.org\/10.1016\/B978-0-12-815799-2.00013-7","DOI":"10.1016\/B978-0-12-815799-2.00013-7"},{"key":"2386_CR5","doi-asserted-by":"publisher","unstructured":"Gurumukhi VC, Bari SB. Development of ritonavir-loaded nanostructured lipid carriers employing quality by Design (QbD) as a tool: characterizations, permeability, and bioavailability studies. Drug Delivery and Translational Research. 2021:1\u201321. Available from: https:\/\/doi.org\/10.1007\/s13346-021-01083-5","DOI":"10.1007\/s13346-021-01083-5"},{"key":"2386_CR6","doi-asserted-by":"publisher","unstructured":"Gurumukhi VC, Bari SB. Quality by Design (QbD)\u2013based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies. Drug Delivery and Translational Research. 2022;12(5):1230\u201352. Available from: https:\/\/doi.org\/10.1007\/s13346-021-01014-4","DOI":"10.1007\/s13346-021-01014-4"},{"key":"2386_CR7","doi-asserted-by":"publisher","unstructured":"Gurumukhi VC, Bari SB. Fabrication of efavirenz loaded nano-formulation using quality by Design (QbD) based approach: exploring characterizations and in vivo safety. Journal of Drug Delivery Science and Technology. 2020;56:101545. Available from:\u00a0https:\/\/doi.org\/10.21203\/rs.3.rs-198073\/v1","DOI":"10.21203\/rs.3.rs-198073\/v1"},{"key":"2386_CR8","doi-asserted-by":"publisher","unstructured":"Mahmood A, Rapalli VK, Gorantla S, Waghule T, Singhvi G. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations. Drug Delivery and Translational Research. 2022;12(5):1118\u201335. Available from: https:\/\/doi.org\/10.1007\/s13346-021-00986-7","DOI":"10.1007\/s13346-021-00986-7"},{"key":"2386_CR9","doi-asserted-by":"publisher","unstructured":"Rao RR, Pisay M, Kumar S, Kulkarni S, Pandey A, Kulkarni VI, et al. Medium and large scale preparation of Nanostructured Lipid Carriers of asenapine maleate: Quality-by-design based optimization, production, characterization and performance evaluation. Journal of Drug Delivery Science and Technology. 2022:103275. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.jddst.2022.103275.","DOI":"10.1016\/j.jddst.2022.103275"},{"key":"2386_CR10","doi-asserted-by":"publisher","unstructured":"Mishra V, Thakur S, Patil A, Shukla A. Quality by Design (QbD) approaches in current pharmaceutical set-up. Expert opinion on drug delivery. 2018;15(8):737\u201358. Available from: https:\/\/doi.org\/10.1080\/17425247.2018.150476","DOI":"10.1080\/17425247.2018.150476"},{"key":"2386_CR11","doi-asserted-by":"publisher","unstructured":"Alam T, Khan S, Gaba B, Haider MF, Baboota S, Ali J. Adaptation of quality by design-based development of isradipine nanostructured\u2013lipid carrier and its evaluation for in vitro gut permeation and in vivo solubilization fate. Journal of pharmaceutical sciences. 2018;107(11):2914\u201326. Available from: https:\/\/doi.org\/10.1016\/j.xphs.2018.07.021","DOI":"10.1016\/j.xphs.2018.07.021"},{"key":"2386_CR12","doi-asserted-by":"publisher","unstructured":"Rangaraj N, Pailla SR, Shah S, Prajapati S, Sampathi S. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach. Drug Delivery and Translational Research. 2020;10(5):1476\u201394. Available from:\u00a0https:\/\/doi.org\/10.1007\/s13346-020-00803-7","DOI":"10.1007\/s13346-020-00803-7"},{"key":"2386_CR13","doi-asserted-by":"publisher","unstructured":"Rapalli VK, Khosa A, Singhvi G, Girdhar V, Jain R, Dubey SK. Application of QbD principles in nanocarrier-based drug delivery systems. Pharmaceutical quality by Design: Elsevier; 2019. p. 255\u201396. Available from: https:\/\/doi.org\/10.1016\/B978-0-12-815799-2.00014-9","DOI":"10.1016\/B978-0-12-815799-2.00014-9"},{"key":"2386_CR14","doi-asserted-by":"publisher","unstructured":"Shah B, Khunt D, Bhatt H, Misra M, Padh H. Intranasal delivery of venlafaxine loaded nanostructured lipid carrier: Risk assessment and QbD based optimization. Journal of Drug Delivery Science and Technology. 2016;33:37\u201350. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.jddst.2016.03.008","DOI":"10.1016\/j.jddst.2016.03.008"},{"key":"2386_CR15","doi-asserted-by":"publisher","unstructured":"Nabi B, Rehman S, Baboota S, Ali J. Insights on oral drug delivery of lipid nanocarriers: a win-win solution for augmenting bioavailability of antiretroviral drugs. AAPS PharmSciTech. 2019;20(2):1\u201311. Available from: https:\/\/doi.org\/10.1208\/s12249-018-1284-9","DOI":"10.1208\/s12249-018-1284-9"},{"issue":"3","key":"2386_CR16","first-page":"1547","volume":"6","author":"M Pg","year":"2022","unstructured":"Pg M, Somasundaram I. Enhancement Of Bioavilability of Perinodopril Using Lipid Based Nanocarrier Mediated Oral Drug Delivery System. Journal of Positive School Psychology. 2022;6(3):1547\u201352.","journal-title":"Journal of Positive School Psychology"},{"key":"2386_CR17","doi-asserted-by":"publisher","unstructured":"Khan SA, Rehman S, Nabi B, Iqubal A, Nehal N, Fahmy UA, et al. Boosting the brain delivery of Atazanavir through nanostructured lipid carrier-based approach for mitigating neuroaids. Pharmaceutics. 2020;12(11):1059. Available from:\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics12111059","DOI":"10.3390\/pharmaceutics12111059"},{"key":"2386_CR18","doi-asserted-by":"publisher","unstructured":"Hippalgaonkar K, Adelli GR, Hippalgaonkar K, Repka MA, Majumdar S. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. Journal of ocular pharmacology and therapeutics. 2013;29(2):216\u201328. Available from: DOI:\u00a0https:\/\/doi.org\/10.1089\/jop.2012.0069","DOI":"10.1089\/jop.2012.0069"},{"key":"2386_CR19","doi-asserted-by":"publisher","unstructured":"Gupta B, Poudel BK, Tran TH, Pradhan R, Cho H-J, Jeong J-H, et al. Modulation of pharmacokinetic and cytotoxicity profile of imatinib base by employing optimized nanostructured lipid carriers. Pharmaceutical research. 2015;32(9):2912--27. Available from: DOI: https:\/\/doi.org\/10.1007\/s11095-015-1673-7","DOI":"10.1007\/s11095-015-1673-7"},{"key":"2386_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-981-33-4351-1_7","volume-title":"Design of Experiments for the Development of Ophthalmic Products","author":"R Suri","year":"2021","unstructured":"Suri R. Design of Experiments for the Development of Ophthalmic Products. Design of Experiments for Pharmaceutical Product Development: Springer; 2021. p. 117\u201327."},{"key":"2386_CR21","doi-asserted-by":"publisher","unstructured":"Loh ZH, Samanta AK, Heng PWS. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian journal of pharmaceutical sciences. 2015;10(4):255\u201374. Available from: https:\/\/doi.org\/10.1016\/j.ajps.2014.12.006","DOI":"10.1016\/j.ajps.2014.12.006"},{"issue":"4","key":"2386_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cocis.2008.01.005","volume":"13","author":"J Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez J, Gonz\u00e1lez C, Maestro A, Sol\u00e8 I, Pey C, Nolla J. Nano-emulsions: New applications and optimization of their preparation. Curr Opin Colloid Interface Sci. 2008;13(4):245\u201351.","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"2386_CR23","doi-asserted-by":"publisher","unstructured":"Peptu C, Rotaru R, Ignat L, Cristina Humelnicu A, Harabagiu V, Anisoara Peptu C, et al. Nanotechnology approaches for pain therapy through transdermal drug delivery. Current pharmaceutical Design. 2015;21(42):6125\u201339. Available from:\u00a0https:\/\/doi.org\/10.2174\/1381612821666151027152752","DOI":"10.2174\/1381612821666151027152752"},{"key":"2386_CR24","doi-asserted-by":"publisher","unstructured":"Son G-H, Na Y-G, Huh HW, Wang M, Kim M-K, Han M-G, et al. Systemic Design and evaluation of ticagrelor-loaded nanostructured lipid carriers for enhancing bioavailability and antiplatelet activity. Pharmaceutics. 2019;11(5):222. Available from: https:\/\/doi.org\/10.3390\/pharmaceutics11050222","DOI":"10.3390\/pharmaceutics11050222"},{"key":"2386_CR25","doi-asserted-by":"publisher","unstructured":"Kaspera R, Kirby BJ, Sahele T, Collier AC, Kharasch ED, Unadkat JD, et al. Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo. Biochem Pharmacol. 2014;91:109\u201318. Available from: https:\/\/doi.org\/10.1016\/j.bcp.2014.06.020","DOI":"10.1016\/j.bcp.2014.06.020"},{"key":"2386_CR26","doi-asserted-by":"publisher","unstructured":"Sudhakar B, Krishna MC, Murthy KVR. Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilization and pharmacokinetic studies. Appl Nanosci [Internet]. Springer Berlin Heidelberg; 2016;6:43\u201360. Available from:\u00a0https:\/\/doi.org\/10.1007\/s13204-015-0408-8","DOI":"10.1007\/s13204-015-0408-8"},{"key":"2386_CR27","doi-asserted-by":"publisher","unstructured":"Makwana V, Jain R, Patel K, Nivsarkar M, Joshi A. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm [Internet]. Elsevier BV; 2015;495:439\u201346. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.ijpharm.2015.09.014","DOI":"10.1016\/j.ijpharm.2015.09.014"},{"key":"2386_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2394-2002.148880","volume":"6","author":"D Patel","year":"2015","unstructured":"Patel D, Patel B, Patel C. Spectrophotometric method for simultaneous estimation of atazanavir sulfate and ritonavir in tablet dosage form. Drug Dev Ther. 2015;6:1.","journal-title":"Drug Dev Ther"},{"key":"2386_CR29","doi-asserted-by":"publisher","unstructured":"Karakucuk A, Celebi N, Teksin ZS. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach. Eur J Pharm Sci [Internet]. Elsevier BV; 2016;95:111\u201321. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.ejps.2016.05.010","DOI":"10.1016\/j.ejps.2016.05.010"},{"key":"2386_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/jphp.12737","volume":"69","author":"F Javan","year":"2017","unstructured":"Javan F, Vatanara A, Azadmanesh K, Nabi-Meibodi M, Shakouri M. Encapsulation of ritonavir in solid lipid nanoparticles: in-vitro anti-HIV-1 activity using lentiviral particles. J Pharm Pharmacol. 2017;69:1002\u20139.","journal-title":"J Pharm Pharmacol"},{"key":"2386_CR31","first-page":"235","volume":"3","author":"R Yogananda","year":"2013","unstructured":"Yogananda R, Chowdary KPR. Enhancement of solubility, dissolution rate and bioavailability of efavirenz by Cyclodextrins and Solutol HS15 - a factorial study. Int J Res Pharm Chem. 2013;3:235\u20139.","journal-title":"Int J Res Pharm Chem"},{"key":"2386_CR32","doi-asserted-by":"publisher","unstructured":"Patil-Gadhe A, Pokharkar V. Montelukast-loaded nanostructured lipid carriers\u202f: Part I Oral bioavailability improvement. Eur J Pharm Biopharm [Internet]. Elsevier BV; 2014;88:160\u20138. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.ejpb.2014.05.019","DOI":"10.1016\/j.ejpb.2014.05.019"},{"key":"2386_CR33","doi-asserted-by":"publisher","unstructured":"Rainer HM, Ranjita S, Cornelia MK. 20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. Curr Drug Discov Technol. 2011;8(3):207\u201327. Available from: https:\/\/doi.org\/10.2174\/157016311796799062.","DOI":"10.2174\/157016311796799062"},{"key":"2386_CR34","doi-asserted-by":"publisher","unstructured":"Beloqui A, del Pozo-Rodr\u00edguez A, Isla A, Rodr\u00edguez-Gasc\u00f3n A, Solin\u00eds M\u00c1. Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs. Journal of Drug Delivery Science and Technology. 2017;42:144\u201354. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.jddst.2017.06.013.","DOI":"10.1016\/j.jddst.2017.06.013"},{"key":"2386_CR35","doi-asserted-by":"publisher","unstructured":"Pandya P, Giram P, Bhole RP, Chang HI, Raut SY. Nanocarriers based oral lymphatic drug targeting: strategic bioavailability enhancement approaches. J Drug Delivery Sci Technol. 2021:102585. Available from: https:\/\/doi.org\/10.1016\/j.jddst.2021.102585.","DOI":"10.1016\/j.jddst.2021.102585"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02386-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02386-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02386-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T16:14:25Z","timestamp":1666714465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02386-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2386"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02386-7","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declare no competing interests. We certify that the submission is an original work and is not under submmited to any other journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"253"}}